DE69919191D1 - Heilmittel für die stenose des rückenmarkkanals - Google Patents

Heilmittel für die stenose des rückenmarkkanals

Info

Publication number
DE69919191D1
DE69919191D1 DE69919191T DE69919191T DE69919191D1 DE 69919191 D1 DE69919191 D1 DE 69919191D1 DE 69919191 T DE69919191 T DE 69919191T DE 69919191 T DE69919191 T DE 69919191T DE 69919191 D1 DE69919191 D1 DE 69919191D1
Authority
DE
Germany
Prior art keywords
stenosis
canal
medicine
hydrogen atom
back mark
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919191T
Other languages
English (en)
Other versions
DE69919191T2 (de
Inventor
Tomoyuki Maruyama
Toru Kawamura
Toshiaki Akira
Hideaki Kido
Norifumi Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Application granted granted Critical
Publication of DE69919191D1 publication Critical patent/DE69919191D1/de
Publication of DE69919191T2 publication Critical patent/DE69919191T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69919191T 1998-09-01 1999-08-30 Heilmittel für die stenose des rückenmarkkanals Expired - Lifetime DE69919191T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24688698 1998-09-01
JP24688698 1998-09-01
PCT/JP1999/004690 WO2000012091A1 (en) 1998-09-01 1999-08-30 Remedies for spinal canal stenosis

Publications (2)

Publication Number Publication Date
DE69919191D1 true DE69919191D1 (de) 2004-09-09
DE69919191T2 DE69919191T2 (de) 2005-07-28

Family

ID=17155219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919191T Expired - Lifetime DE69919191T2 (de) 1998-09-01 1999-08-30 Heilmittel für die stenose des rückenmarkkanals

Country Status (15)

Country Link
US (1) US6369061B1 (de)
EP (1) EP1123704B1 (de)
JP (1) JP4366865B2 (de)
KR (1) KR100573376B1 (de)
CN (1) CN1137686C (de)
AT (1) ATE272401T1 (de)
AU (1) AU5445699A (de)
CA (1) CA2342198C (de)
DE (1) DE69919191T2 (de)
DK (1) DK1123704T3 (de)
ES (1) ES2221421T3 (de)
PT (1) PT1123704E (de)
RU (1) RU2229297C2 (de)
TW (1) TW544312B (de)
WO (1) WO2000012091A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167403A1 (en) * 2003-04-03 2007-07-19 Yoshifumi Takenobu Remedy for spinal canal stenosis
EP1698339A4 (de) * 2003-12-26 2009-06-17 Nissan Chemical Ind Ltd Neutrophilie-hemmer
US20070161642A1 (en) * 2004-02-09 2007-07-12 Nissan Chemical Industries Ltd. Drug for inhibiting vascular intimal hyperplasia
KR20110098965A (ko) 2008-12-23 2011-09-02 화이자 인코포레이티드 척추관 협착증 치료용 ５－ｈｔ２ａ 및 ５－ｈｔ２ｂ 수용체 길항제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970002876B1 (ko) 1990-04-25 1997-03-12 닛산가가꾸고오교 가부시끼가이샤 피리다지논 유도체
JP3806945B2 (ja) * 1994-01-21 2006-08-09 三菱ウェルファーマ株式会社 ヒト由来アンチトロンビン−ｉｉｉの新規用途
US5750523A (en) * 1994-01-25 1998-05-12 Nissan Chemical Industries, Ltd. Pyridazinone derivatives
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
JPH09227411A (ja) * 1996-02-26 1997-09-02 Sumitomo Pharmaceut Co Ltd 脊髄損傷による神経障害治療剤

Also Published As

Publication number Publication date
AU5445699A (en) 2000-03-21
DE69919191T2 (de) 2005-07-28
US6369061B1 (en) 2002-04-09
ES2221421T3 (es) 2004-12-16
WO2000012091A1 (en) 2000-03-09
EP1123704A1 (de) 2001-08-16
DK1123704T3 (da) 2004-11-01
CA2342198C (en) 2007-08-28
EP1123704A4 (de) 2001-10-10
JP4366865B2 (ja) 2009-11-18
RU2229297C2 (ru) 2004-05-27
KR20010086361A (ko) 2001-09-10
TW544312B (en) 2003-08-01
PT1123704E (pt) 2004-10-29
CN1137686C (zh) 2004-02-11
CN1325307A (zh) 2001-12-05
EP1123704B1 (de) 2004-08-04
ATE272401T1 (de) 2004-08-15
KR100573376B1 (ko) 2006-04-25
CA2342198A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
HK1046639B (zh) 含有硝基咪唑的皮膚病外用藥
DK0841929T3 (da) Quinoloner og deres terapeutiske anvendelse
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
PT1003725E (pt) Fungicidas de fluoropirazoldifenilamidas
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
DE60121461D1 (de) Kondensierte pyridoindolderivate
TR200001950T2 (tr) İkameli 2-benzilamino-2-fenil-asetamid bileşikler.
DK1454903T3 (da) Thiadiazolinderivater til behandling af cancer
BR9900623A (pt) Parasiticidas derivados de pirazóis.
IN165718B (de)
DE69919191D1 (de) Heilmittel für die stenose des rückenmarkkanals
ATE187169T1 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ZA200109334B (en) Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance.
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
SE9704770D0 (sv) New use
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine
DE69624459D1 (de) Kondensierte indan-derivate und ihre salze
RU2001108574A (ru) Терапевтический агент для лечения стеноза позвоночного канала
EP0919233B8 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
ATE157874T1 (de) Mittel zur verbesserung der peripheren durchblutung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition